Venturi Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Venturi Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Hold	3,061	–	–	0.01%	555
2026 Q1	$230K	Hold	3,061	–	–	0.01%	540
2025 Q4	$242K	Buy	+3,061	New	+$230K	0.01%	502
2025 Q1	–	Sell	-3,061	Closed	-$107K	–	1206
2024 Q4	$107K	Buy	+3,061	New	+$114K	0.01%	745

Other funds holding IONS

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return

Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

SWP

Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return

Cypress Capital Franklin, Tennessee $370M AUM 16.36% 1-Year Est. Return

Venturi Wealth Management's IONS Position: Q2 2026 in Review

Venturi Wealth Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 3,061 shares worth $243K. The position accounts for 0.01% of the portfolio, ranked #555.

Venturi Wealth Management first reported a position in IONS in Q4 2024 and has held it in 4 quarters since. 54 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Venturi Wealth Management held 3,061 shares of Ionis Pharmaceuticals worth $243K as of Q2 2026.
Venturi Wealth Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
Ionis Pharmaceuticals made up 0.01% of Venturi Wealth Management's portfolio in Q2 2026, its #555 holding.
Venturi Wealth Management first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
54 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.